Clorox Q2 2024 Adj EPS $2.16 Beats $1.10 Estimate, Sales $1.99B Beat $1.80B Estimate
Portfolio Pulse from Benzinga Newsdesk
Clorox reported Q2 2024 adjusted EPS of $2.16, surpassing the $1.10 estimate, with sales of $1.99B also beating the $1.80B estimate. This represents a 16.03% increase in sales compared to the same period last year.
February 01, 2024 | 9:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Clorox's Q2 2024 earnings and sales significantly exceeded analyst expectations, with a notable year-over-year sales growth.
Clorox's substantial beat on both earnings per share and sales estimates, coupled with a significant year-over-year sales increase, is likely to positively impact investor sentiment and the stock price in the short term. The magnitude of the beat and growth rate are key factors driving this analysis.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100